Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
Completed
Conditions studied: Brain and Central Nervous System Tumors, Chemotherapeutic Agent Toxicity, Infertility
In brief
RATIONALE: Learning whether temozolomide changes semen or sperm in patients with brain tumors may help doctors learn about the long-term effects of treatment and plan the best treatment. PURPOSE: This clinical trial is studying changes in semen or sperm caused by temozolomide in patients with newly diagnosed, progressive, or recurrent primary malignant brain tumors.
Key facts
- Study ID
- NCT00499798
- Run by
- Wake Forest University Health Sciences
- People needed
- 16
- Starts
- 2004-08-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2017-05-30
Who can join
Age: 18 and older, up to 60. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.